Ardent Health Partners (NYSE:ARDT) Earns Overweight Rating from Stephens

Stephens reiterated their overweight rating on shares of Ardent Health Partners (NYSE:ARDT) in a research note released on Tuesday,Benzinga reports. The brokerage currently has a $22.00 price target on the stock.

ARDT has been the subject of several other reports. Morgan Stanley lowered their price target on Ardent Health Partners from $23.50 to $22.00 and set an “overweight” rating for the company in a report on Tuesday, January 21st. Truist Financial decreased their price objective on Ardent Health Partners from $22.00 to $21.00 and set a “buy” rating for the company in a research report on Monday, January 6th. Royal Bank of Canada dropped their target price on shares of Ardent Health Partners from $23.00 to $21.00 and set an “outperform” rating on the stock in a report on Tuesday, March 4th. Finally, JPMorgan Chase & Co. reaffirmed a “neutral” rating and issued a $20.00 price target on shares of Ardent Health Partners in a research note on Tuesday, December 17th. Two analysts have rated the stock with a hold rating, eight have given a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Buy” and an average price target of $21.18.

Ardent Health Partners Stock Performance

Ardent Health Partners stock opened at $12.92 on Tuesday. Ardent Health Partners has a fifty-two week low of $12.39 and a fifty-two week high of $20.72. The company has a debt-to-equity ratio of 0.78, a current ratio of 1.91 and a quick ratio of 1.78. The company’s 50 day simple moving average is $14.38 and its 200 day simple moving average is $16.15.

Ardent Health Partners (NYSE:ARDT) last announced its quarterly earnings results on Wednesday, February 26th. The company reported $0.81 earnings per share for the quarter, topping analysts’ consensus estimates of $0.50 by $0.31. The firm had revenue of $1.61 billion for the quarter, compared to the consensus estimate of $1.48 billion. As a group, equities analysts anticipate that Ardent Health Partners will post 1.23 EPS for the current fiscal year.

Institutional Trading of Ardent Health Partners

A number of institutional investors have recently made changes to their positions in ARDT. Squarepoint Ops LLC grew its position in Ardent Health Partners by 1.8% in the fourth quarter. Squarepoint Ops LLC now owns 101,798 shares of the company’s stock valued at $1,739,000 after purchasing an additional 1,798 shares in the last quarter. State of Wyoming boosted its stake in shares of Ardent Health Partners by 123.3% during the 4th quarter. State of Wyoming now owns 31,693 shares of the company’s stock worth $541,000 after buying an additional 17,499 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. bought a new position in shares of Ardent Health Partners in the 4th quarter valued at about $27,000. Point72 Asset Management L.P. increased its position in shares of Ardent Health Partners by 7.9% in the fourth quarter. Point72 Asset Management L.P. now owns 1,609,720 shares of the company’s stock valued at $27,494,000 after acquiring an additional 117,421 shares during the last quarter. Finally, Nuveen Asset Management LLC increased its position in shares of Ardent Health Partners by 220.6% in the fourth quarter. Nuveen Asset Management LLC now owns 169,475 shares of the company’s stock valued at $2,895,000 after acquiring an additional 116,610 shares during the last quarter.

Ardent Health Partners Company Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.